Maintenance Pharmacotherapies for Neuropsychiatric DisordersPsychology Press, 1999 - 394 páginas Designed for clinicians from a variety of backgrounds, this handbook provides indispensable information regarding long-term treatment of neuropsychiatric disorders. Aware of the changing nature of the mental health care environment, Maintenance Pharmacotherapies for Neuropsychiatric Disorders is intended not only for psychiatrists and neurologists but also for primary care physicians and nonphysician mental health professionals. The book examines maintenance treatment for a comprehensive list of mental illnesses, including bipolar disorders, anxiety disorders, schizophrenia, and dementia. This volume provides clinicians with the information needed to select and manage the effective long-range treatment of their patients. |
Índice
ROLE | 1 |
PHARMACOKINETICS | 17 |
PHARMACOECONOMICS | 29 |
BIPOLAR ILLNESS | 145 |
SCHIZOPHRENIA | 187 |
ANXIETY DISORDERS | 249 |
SEIZURE DISORDERS | 283 |
PARKINSONS DISEASE | 299 |
MULTIPLE SCLEROSIS | 305 |
DEMENTIA | 311 |
PSYCHIATRIC SEQUELAE | 337 |
CHRONIC PAIN | 343 |
TRAUMATIC BRAIN INJURY | 369 |
Otras ediciones - Ver todo
Maintenance Pharmacotherapies for Neuropsychiatric Disorders Stephanie Richards Vista previa restringida - 2013 |
Maintenance Pharmacotherapies for Neuropsychiatric Disorders Stephanie Richards Vista previa restringida - 2013 |
Maintenance Pharmacotherapies for Neuropsychiatric Disorders Stephanie Richards No hay ninguna vista previa disponible - 2015 |
Términos y frases comunes
abnormalities acute treatment affective disorder alprazolam amitriptyline analysis anticholinergic antipsychotic anxiety disorder Arch Gen Psychiatry associated behavior benzodiazepines bipolar disorder bipolar illness bipolar patients bupropion buspirone carbamazepine cardiac cause chronic pain Clin Psychiatry clinical clomipramine clozapine comorbid costs criteria decanoate decrease delirium dementia depressive disorders depressive episode depressive symptoms diagnosis discontinuation disease dopamine dosage double-blind drug efficacy elderly epilepsy fluoxetine fluvoxamine functioning half-life haloperidol imipramine increased infection inhibitors interactions lithium long-term maintenance therapy maintenance treatment major depression mania manic MAOIS medical condition metabolism mg/day monitored mood neuroleptic neuropsychiatric onset oral outcome panic disorder paroxetine pharmacoeconomic pharmacological placebo placebo-controlled plasma level post-stroke potency agents primary Psychiatry psychosis psychotic symptoms psychotropics receptors recurrent relapse reported Reprinted with permission response risk schizophrenia seizures serotonin sertraline side effects SSRIs suicide syndrome TABLE tardive dyskinesia TCAs therapeutic tolerated toxicity trazodone treated trial tricyclic antidepressants valproate weeks
Referencias a este libro
Pharmacotherapy for Child and Adolescent Psychiatric Disorders David Rosenberg,Samuel Gershon No hay ninguna vista previa disponible - 2002 |